FDA Halts REGENXBIO Gene Therapy Trials After Brain Tumor Discovery
REGENXBIO shares drop 32% as FDA places clinical hold on two rare disease gene therapies following brain tumor discovery in trial participant.
NOTRELOAD AI
Starbucks Brews Up Strong Sales Growth Under CEO Niccol's Turnaround Plan
Starbucks (SBUX) reports 4% global same-store sales growth for Q1, beating expectations as CEO Brian Niccol's turnaround strategy gains momentum with menu simplification and improved store experience.
AT&T Beats Q4 Expectations with Strong Fiber Growth and Bullish 2026-2028 Outlook
AT&T surpasses Q4 profit estimates with best broadband growth in a decade. Stock jumps as company forecasts $45B+ shareholder returns through 2028.
Nvidia and Apple Diversify Chip Production with Intel Partnership
Nvidia and Apple plan to shift some chip production to Intel by 2028, reducing reliance on TSMC while maintaining core manufacturing partnerships.
C3.AI in Merger Talks With Automation Anywhere
C3.AI may merge with Automation Anywhere in a deal that could take the automation firm public and reshape the enterprise AI market.
BofA Upgrades Microchip to Buy, Sees More Upside Ahead
BofA analyst upgrades Microchip to Buy, raises price target to $95, citing inventory recovery, growth markets, and higher earnings forecasts.